Literature DB >> 31789244

Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects (Corrigir nos altos de página onde tem o título).

Clarissa Prieto Herman Reinehr1, Renato Marchiori Bakos2.   

Abstract

Actinic keratoses are dysplastic proliferations of keratinocytes with potential for malignant transformation. Clinically, actinic keratoses present as macules, papules, or hyperkeratotic plaques with an erythematous background that occur on photoexposed areas. At initial stages, they may be better identified by palpation rather than by visual inspection. They may also be pigmented and show variable degrees of infiltration; when multiple they then constitute the so-called field cancerization. Their prevalence ranges from 11% to 60% in Caucasian individuals above 40 years. Ultraviolet radiation is the main factor involved in pathogenesis, but individual factors also play a role in the predisposing to lesions appearance. Diagnosis of lesions is based on clinical and dermoscopic examination, but in some situations histopathological analysis may be necessary. The risk of transformation into squamous cell carcinoma is the major concern regarding actinic keratoses. Therapeutic modalities for actinic keratoses include topical medications, and ablative and surgical methods; the best treatment option should always be individualized according to the patient.
Copyright © 2019. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  Dermoscopy; Keratosis, actinic; Neoplasms, squamous cell; Precancerous conditions; Skin neoplasms

Year:  2019        PMID: 31789244     DOI: 10.1016/j.abd.2019.10.004

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  13 in total

Review 1.  Diagnostic Accuracy of Dermoscopy of Actinic Keratosis: A Systematic Review.

Authors:  Karla L Valdés-Morales; María Luisa Peralta-Pedrero; Fermín Jurado-Santa Cruz; Martha Alejandra Morales-Sánchez
Journal:  Dermatol Pract Concept       Date:  2020-10-26

2.  Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.

Authors:  Aleksandra Rymsza; Karolina Świerczyńska; Aleksandra Piotrowska; Piotr Dzięgiel; Jacek C Szepietowski
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 3.  A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Authors:  Benjamin Genenger; Jay R Perry; Bruce Ashford; Marie Ranson
Journal:  Discov Oncol       Date:  2022-06-06

4.  Efficacy of intermittent topical 5-fluorouracil 5% and oral nicotinamide in the skin field cancerization: a randomized clinical trial.

Authors:  Eliane Roio Ferreira; Anna Carolina Miola; Thania Rios Rossi Lima; Juliano Vilaverde Schmitt; Luciana Patricia Fernandes Abbade; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2021-09-10       Impact factor: 1.896

Review 5.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

6.  Characterization of the Biomechanical Properties of Skin Using Vibrational Optical Coherence Tomography: Do Changes in the Biomechanical Properties of Skin Stroma Reflect Structural Changes in the Extracellular Matrix of Cancerous Lesions?

Authors:  Frederick H Silver; Nikita Kelkar; Tanmay Deshmukh; Kelly Ritter; Nicole Ryan; Hari Nadiminti
Journal:  Biomolecules       Date:  2021-11-17

7.  Ingol and Ingenol-Type Diterpenes from Euphorbia trigona Miller with Keratinocyte Inhibitory Activity.

Authors:  Reham Hammadi; Norbert Kúsz; Csilla Zsuzsanna Dávid; Zoltán Behány; László Papp; Lajos Kemény; Judit Hohmann; Lóránt Lakatos; Andrea Vasas
Journal:  Plants (Basel)       Date:  2021-06-14

8.  Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID-19 pandemic.

Authors:  Ömer Kutlu
Journal:  Dermatol Ther       Date:  2020-07-27       Impact factor: 3.858

9.  Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Markus V Heppt; Igor Dykukha; Sara Graziadio; Rafael Salido-Vallejo; Matt Chapman-Rounds; Mary Edwards
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

Review 10.  1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.

Authors:  Diem-Phuong D Dao; Vikram Nath Sahni; Dev Ram Sahni; Esther A Balogh; Ayman Grada; Steven R Feldman
Journal:  Ann Pharmacother       Date:  2021-07-23       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.